Versant Ventures VII GP, L.P. is 10% Owner at LENZ Therapeutics, Inc. (LENZ). They have made 1 open-market trade across 1 company since 2025, most recently 2025-08-26.
CIK 0001777655
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LENZ | 952,802 | $3.1M |
Shares reported on the most recent Form 4, priced at the 2025-08-26 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LENZ | SELL | 2025-08-22 | 2025-08-26 | $39.47 | $14.8M | +2.9% | +3.9% | -17.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.